Eric A. Pierce

Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis

Albert M. Maguire, Francesca Simonelli, Eric A. Pierce et al. · New England Journal of Medicine · 2008 · 2.1K citations · Full text

Medicine, Genetics, Ophthalmology +17

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

Lloyd Paul Aiello, Eric A. Pierce, E D Foley et al. · Proceedings of the National Academy of Sciences · 1995 · 1.3K citations · Full text

Medicine, Ophthalmology, Vision Science +16

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

Eric A. Pierce, Robert L. Avery, E D Foley et al. · Proceedings of the National Academy of Sciences · 1995 · 1K citations · Full text

Medicine, Molecular Biology, Ophthalmology +12

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

Albert M. Maguire, Katherine A. High, Alberto Auricchio et al. · The Lancet · 2009 · 858 citations

Medicine, Genetics, Molecular Genetics +12

Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration

Francesca Simonelli, Albert M. Maguire, Francesco Testa et al. · Molecular Therapy · 2009 · 551 citations · Full text

Medicine, Immunology, Ophthalmology +15